Cargando…
Targeting the EGF receptor family in non-small cell lung cancer—increased complexity and future perspectives
Lung cancer remains the leading cause of cancer-associated mortality worldwide, but with the emergence of oncogene targeted therapies, treatment options have tremendously improved. Owing to their biological relevance, members of the ERBB receptor family, including the EGF receptor (EGFR), HER2, HER3...
Autores principales: | Boch, Tobias, Köhler, Jens, Janning, Melanie, Loges, Sonja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Compuscript
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724226/ https://www.ncbi.nlm.nih.gov/pubmed/36476337 http://dx.doi.org/10.20892/j.issn.2095-3941.2022.0540 |
Ejemplares similares
-
Influence of Androgens on Immunity to Self and Foreign: Effects on Immunity and Cancer
por: Ben-Batalla, Isabel, et al.
Publicado: (2020) -
Detection of Circulating Tumor Cells in Non-Small Cell Lung Cancer
por: Hanssen, Annkathrin, et al.
Publicado: (2015) -
Multivesicular endosomes containing internalized EGF-EGF receptor complexes mature and then fuse directly with lysosomes
Publicado: (1996) -
The EGF receptor family as targets for breast cancer therapy
por: Baselga, J
Publicado: (2000) -
Back to EGF+61 genetic polymorphisms and lung cancer risk: looking to the future!
por: Mello, Ramon Andrade De
Publicado: (2013)